EP1365790A4 - Indicateur de diagnostic de la fonction thymique - Google Patents

Indicateur de diagnostic de la fonction thymique

Info

Publication number
EP1365790A4
EP1365790A4 EP01986579A EP01986579A EP1365790A4 EP 1365790 A4 EP1365790 A4 EP 1365790A4 EP 01986579 A EP01986579 A EP 01986579A EP 01986579 A EP01986579 A EP 01986579A EP 1365790 A4 EP1365790 A4 EP 1365790A4
Authority
EP
European Patent Office
Prior art keywords
diagnostic indicator
thymic function
thymic
function
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01986579A
Other languages
German (de)
English (en)
Other versions
EP1365790A2 (fr
Inventor
Richard Boyd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norwood Immunology Ltd
Original Assignee
Monash University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR0745A external-priority patent/AUPR074500A0/en
Priority claimed from US09/755,965 external-priority patent/US20010046486A1/en
Application filed by Monash University filed Critical Monash University
Publication of EP1365790A2 publication Critical patent/EP1365790A2/fr
Publication of EP1365790A4 publication Critical patent/EP1365790A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5418—IL-7
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5759—Thymosin or related peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Prostheses (AREA)
  • Road Signs Or Road Markings (AREA)
EP01986579A 2000-10-13 2001-10-12 Indicateur de diagnostic de la fonction thymique Withdrawn EP1365790A4 (fr)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US79530200A 2000-10-13 2000-10-13
US79528600A 2000-10-13 2000-10-13
US795286 2000-10-13
AUPR074500 2000-10-13
US795302 2000-10-13
AUPR0745A AUPR074500A0 (en) 2000-10-13 2000-10-13 Treatment of t cell disorders
US75564601A 2001-01-05 2001-01-05
US75598301A 2001-01-05 2001-01-05
US755646 2001-01-05
US755965 2001-01-05
US755983 2001-01-05
US09/755,965 US20010046486A1 (en) 2000-04-17 2001-01-05 Stimulation of thymus for vaccination development
US75891001A 2001-01-10 2001-01-10
US758910 2001-01-10
US09/885,268 US20030017153A1 (en) 2000-10-13 2001-08-01 Diagnostic indicator of thymic function
US885268 2001-08-01
PCT/IB2001/002351 WO2002030256A2 (fr) 2000-10-13 2001-10-12 Indicateur de diagnostic de la fonction thymique

Publications (2)

Publication Number Publication Date
EP1365790A2 EP1365790A2 (fr) 2003-12-03
EP1365790A4 true EP1365790A4 (fr) 2006-05-31

Family

ID=27570137

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01986579A Withdrawn EP1365790A4 (fr) 2000-10-13 2001-10-12 Indicateur de diagnostic de la fonction thymique

Country Status (8)

Country Link
EP (1) EP1365790A4 (fr)
JP (1) JP2004523730A (fr)
CN (1) CN1516597A (fr)
AU (1) AU2002218450A1 (fr)
CA (1) CA2462758A1 (fr)
IL (1) IL155412A0 (fr)
NZ (1) NZ525826A (fr)
WO (1) WO2002030256A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102772783A (zh) * 2007-01-25 2012-11-14 中国生化制药工业协会 血清胸腺因子在制备抗肿瘤药物、肿瘤物理及化学治疗药物的保护药物方面的用途
ES2331499B1 (es) * 2007-08-02 2010-10-14 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud En Sevilla (Fund.Sevilla) Cebadores, procedimiento y conjunto de utiles para la determinacion d e la funcionalidad del timo humano.
KR101604649B1 (ko) * 2007-11-27 2016-03-18 베리덱스, 엘엘씨 혈액 내 순환 흑색종 세포의 자동화된 계산 및 특징화
DE102008057479A1 (de) 2008-11-14 2010-05-20 Bernhard, Stefan, Dr. Vorrichtung und Verfahren zur Stärkung des Immunsystems durch Langzeitstimulation der Thymusdrüse
US11794040B2 (en) 2010-01-19 2023-10-24 The Board Of Regents Of The University Of Texas System Apparatuses and systems for generating high-frequency shockwaves, and methods of use
US11865371B2 (en) 2011-07-15 2024-01-09 The Board of Regents of the University of Texas Syster Apparatus for generating therapeutic shockwaves and applications of same
CN103173534B (zh) * 2012-11-20 2014-08-06 无锡联合利康临床检验所有限公司 一种定量检测TRECs基因的实时荧光定量PCR试剂盒及应用
US10835767B2 (en) 2013-03-08 2020-11-17 Board Of Regents, The University Of Texas System Rapid pulse electrohydraulic (EH) shockwave generator apparatus and methods for medical and cosmetic treatments
AU2016261936B2 (en) 2015-05-12 2020-12-17 Soliton, Inc. Methods of treating cellulite and subcutaneous adipose tissue
TWI742110B (zh) 2016-07-21 2021-10-11 美商席利通公司 具備改良電極壽命之快速脈波電動液壓脈衝產生裝置及使用該裝置生成壓縮聲波之方法
KR20230144665A (ko) 2017-02-19 2023-10-16 솔리톤, 인코포레이티드 생물학적 매체 내의 선택적 레이저 유도 광학 파괴

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP977899A0 (en) * 1999-04-15 1999-05-13 Monash University Improvement of t cell mediated immunity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
WO2002030256A3 (fr) 2002-07-25
CA2462758A1 (fr) 2002-04-18
WO2002030256A9 (fr) 2003-09-12
EP1365790A2 (fr) 2003-12-03
AU2002218450A1 (en) 2002-04-22
NZ525826A (en) 2006-06-30
CN1516597A (zh) 2004-07-28
WO2002030256A2 (fr) 2002-04-18
JP2004523730A (ja) 2004-08-05
IL155412A0 (en) 2003-11-23

Similar Documents

Publication Publication Date Title
AUPQ886100A0 (en) Diagnostic test
AUPR005600A0 (en) Diagnostic assay
GB0009179D0 (en) Non-invasive prenatal diagnosis
EP1346691A4 (fr) Instrument de mesure ultrasonore
IL143739A0 (en) Diagnostic assay
IL155412A0 (en) Diagnostic indicator of thymic function
GB0016392D0 (en) Skin diagnostic aid
AU2002324881A8 (en) Diagnostic and prognostic tests
GB2369761B (en) Bite indicator
EP1457950A4 (fr) Indicateur de periode
GB0027487D0 (en) Home hygiene indicator
AU4962001A (en) Diagnosis of autoimmune disease
GB9815232D0 (en) Diagnostic sensor
EP1372121A4 (fr) Instrument de mesure
GB0224474D0 (en) Handbrake condition indicator
GB0224326D0 (en) Diagnostic tests
GB0108926D0 (en) Indicator
GB0016690D0 (en) Eplthelial diagnostic aid
GB0024938D0 (en) Method of diagnosis
GB9924717D0 (en) Diagnostic
GB0106072D0 (en) Blade-use indicator
GB0001116D0 (en) Diagnosis of toxicoinfectious clostridiosis
GB0025678D0 (en) Diagnostic test
CA96541S (en) Automotive diagnostic tester
GB0002465D0 (en) Medical diagnostic instrument

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030513

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1062394

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20060420

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NORWOOD IMMUNOLOGY, LTD.

17Q First examination report despatched

Effective date: 20081017

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090228

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1062394

Country of ref document: HK